| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety
|
Lee, Young Ran
|
|
|
40 |
10 |
p. 901-913
|
artikel
|
| 2 |
Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions
|
Khalilieh, Sauzanne
|
|
|
40 |
10 |
p. 927-946
|
artikel
|
| 3 |
Community-Acquired Bacterial Pneumonia—Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin
|
Sharma, Roopali
|
|
|
40 |
10 |
p. 947-960
|
artikel
|
| 4 |
Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus
|
McGill, Janet B.
|
|
|
40 |
10 |
p. 973-983
|
artikel
|
| 5 |
Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review
|
Hsieh, Chang-Yu
|
|
|
40 |
10 |
p. 915-926
|
artikel
|
| 6 |
Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
|
Charpiat, Bruno
|
|
|
40 |
10 |
p. 897-899
|
artikel
|
| 7 |
Remifentanil Target-Controlled Infusion for Conscious Sedation in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Case Series
|
Scarlata, Simone
|
|
|
40 |
10 |
p. 985-988
|
artikel
|
| 8 |
The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model
|
Lodise, Thomas P.
|
|
|
40 |
10 |
p. 961-971
|
artikel
|
| 9 |
Use of Azithromycin in COVID-19: A Cautionary Tale
|
Kow, Chia Siang
|
|
|
40 |
10 |
p. 989-990
|
artikel
|
Tijdschrift beschrijving